Human CYP2A6,High-Reductase+b5

• UNSPSC Description:

  Human CYP2A6, High-Reductase+b5, a recombinant CYP2A6, is a member of the CYP enzyme family and is responsible for the metabolic activation of most tobacco carcinogens[1].

• Target Antigen:

  Cytochrome P450

• Type:

  Enzyme

• Related Pathways:

  Metabolic Enzyme/Protease

• Field of Research:

  Metabolic Disease

• Assay Protocol:

  https://www.medchemexpress.com/human-cyp2a6-high-reductase-b5.html

• Smiles:

  [Human CYP2A6,High-Reductase+b5]

• References & Citations:

  [1]Johani FH, et al. Cytochrome P450 2A6 whole-gene deletion (CYP2A6*4) polymorphism reduces risk of lung cancer: A meta-analysis. Tob Induc Dis. 2020 Jun 2;18:50.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported